Pharmaceutical Technology's Equipment and Machinery Trends Survey - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology's Equipment and Machinery Trends Survey
The pharmaceutical industry plans moderate increases in spending for equipment and machinery in 2008. Investments include equipment for solid-dosage manufacturing, active pharmaceutical ingredients, and parenteral manufacturing.


Pharmaceutical Technology
Volume 3, Issue 32

Spending increases for 2008

More than one-third (36.4%) of respondents plan to spend more on pharmaceutical machinery and equipment in 2008 than in 2007, and more than a quarter (26.8%) plan to spend the same amount (see Figure 5). About 16.5% plan to spend less, and 20.3% do not know whether they plan to increase spending.


Figure 5.
For those companies that plan to increase spending in 2008, a critical question is how great the increases. For respondents whose companies plan to spend more in 2008 than in 2007, the mean planned increase in spending is 9.3%. The median increase is 4.1–6%.


Figure 6.
Figure 6 shows the percentage by which respondents say they will increase spending in 2008 compared with 2007. Almost 14% say their planned percentage increase will be less than 2%. Roughly one-third (34.0%) say the increase will be 2.1%–4%, and 30.1% say it will be between 4.1–6%. More than 20% (22.3%) report that their planned increases will be greater than 6% compared with 2007.

Of the respondents whose companies plan to increase their 2008 spending over 2007 levels, 66% say the planned increase is greater than their 2006–2007 increase, 30% say it is on par, and 4% say it is less.

Spending allocation in 2008

An important consideration in assessing spending habits is to determine the types of equipment for planned spending in 2008. Respondents most frequently plan to increase their spending on laboratory equipment (31.6%) and machinery for quality assurance and control (30.9%).

Roughly one-quarter of respondents say they will increase spending in 2008 in the following areas: process control and automation (27.9%), processing (27.9%), packaging (27.6%), API manufacturing (24.7%), cleanrooms (21.6%), and parenteral manufacturing (21.2%).

Solid-dosage manufacturing and environment control ranked as the lowest areas for planned spending in 2008. Only 19.6% of respondents said that they will increase spending for equipment and machinery for solid-dosage manufacturing in 2008, and 16.1% for environmental control.


Figure 7.
Figure 7 shows the areas in which respondents say they will spend the most in 2008. Roughly one-fifth (21.3%) say they plan to spend the most on manufacturing and processing equipment in 2008. Interestingly, although solid-dosage manufacturing was not a popular area for spending, it was one of the areas in which respondents said they plan to spend the most in 2008. Nearly 15% of respondents said that they plan to spend the most for machinery and equipment for solid-dosage manufacturing. Thirteen and one-half percent ranked API manufacturing as the area for their highest spending in 2008, and 13.1% did so for parenteral manufacturing.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
22%
To all process for new products only
12%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here